Ubs Group Ag Gilead Sciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 510,288 shares of GILD stock, worth $45.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

510,288

Previous 4,496,745 88.65%

Holding current value

$45.5 Million

Previous $309 Million 86.14%

% of portfolio

0.01%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $23.9 Million - $30.1 Million	-358,822 Reduced 7.98%	4,137,923 $347 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $17.9 Million - $20.6 Million	282,831 Added 6.71%	4,496,745 $309 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $47.1 Million - $57.4 Million	657,604 Added 18.49%	4,213,914 $309 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $33.1 Million - $37.5 Million	451,397 Added 14.54%	3,556,310 $288 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $18.6 Million - $20.3 Million	-252,070 Reduced 7.51%	3,104,913 $233 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $96.5 Million - $110 Million	1,269,205 Added 60.79%	3,356,983 $259 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $57.5 Million - $65.5 Million	-743,154 Reduced 26.25%	2,087,778 $173 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $37.6 Million - $54 Million	603,988 Added 27.12%	2,830,932 $243 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $36.6 Million - $41.8 Million	-614,137 Reduced 21.62%	2,226,944 $137 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $32.1 Million - $36.1 Million	555,442 Added 24.3%	2,841,081 $176 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $62.9 Million - $78.9 Million	-1,086,698 Reduced 32.22%	2,285,639 $136 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $22.6 Million - $25.7 Million	-348,539 Reduced 9.37%	3,372,337 $245 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $36 Million - $38.8 Million	531,873 Added 16.68%	3,720,876 $260 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $7.98 Million - $8.72 Million	-125,744 Reduced 3.79%	3,189,003 $220 Million
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $12 Million - $13.7 Million	-199,739 Reduced 5.68%	3,314,747 $214 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $12.1 Million - $13.8 Million	-213,285 Reduced 5.72%	3,514,486 $205 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $10.3 Million - $12.9 Million	-165,508 Reduced 4.25%	3,727,771 $236 Million
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $18.9 Million - $22 Million	-261,536 Reduced 6.29%	3,893,279 $300 Million
Q1 2020 May 01, 2020	SELL	$62.63 - $80.22 $72.9 Million - $93.3 Million	-1,163,541 Reduced 21.88%	4,154,815 $311 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $39.9 Million - $43.9 Million	647,904 Added 13.87%	5,318,356 $346 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $7.99 Million - $8.82 Million	-127,834 Reduced 2.66%	4,670,452 $296 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $1.48 Million - $1.66 Million	23,980 Added 0.5%	4,798,286 $324 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $9.37 Million - $10.5 Million	149,925 Added 3.24%	4,774,306 $310 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $64.7 Million - $84.5 Million	-1,069,424 Reduced 18.78%	4,624,381 $289 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $80.9 Million - $89.5 Million	1,134,309 Added 24.88%	5,693,805 $440 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $21.1 Million - $24.6 Million	325,216 Added 7.68%	4,559,496 $323 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $55 Million - $67 Million	-755,036 Reduced 15.13%	4,234,280 $319 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.33 Million - $1.56 Million	-18,732 Reduced 0.37%	4,989,316 $357 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $36.7 Million - $43.5 Million	508,590 Added 11.3%	5,008,048 $406 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-430,696 Reduced 8.74%	4,499,458 $318 Million
Q1 2017 Nov 14, 2017	BUY	N/A	4,930,154	4,930,154 $335 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account